Terazosin Capsule
NDC Package 71335-9607-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Terazosin capsules are indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH). This formulation utilizes a capsule delivery system. Marketed by Bryant Ranch Prepack, this product is identified by NDC 71335-9607 and is authorized under FDA application ANDA075614.

Identification & Billing

NDC Package Code
71335-9607-2
Package Description
28 CAPSULE in 1 BOTTLE
Product Code
71335-9607
11-Digit Billing Format
71335960702
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Terazosin
Non-Proprietary Name
Terazosin
Substance Name
Terazosin Hydrochloride
Dosage Form
Capsule - A solid oral dosage form consisting of a shell and a filling. The shell is composed of a single sealed enclosure, or two halves that fit together and which are sometimes sealed with a band. Capsule shells may be made from gelatin, starch, or cellulose, or other suitable materials, may be soft or hard, and are filled with solid or liquid ingredients that can be poured or squeezed.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
TERAZOSIN HYDROCHLORIDE 10 mg/1
Pharmacologic Class
Usage Information
Terazosin capsules are indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH). There is a rapid response, with approximately 70% of patients experiencing an increase in urinary flow and improvement in symptoms of BPH when treated with terazosin. The long term effects of terazosin on the incidence of surgery, acute urinary obstruction or other complications of BPH are yet to be determined.Terazosin capsules are also indicated for the treatment of hypertension. They can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents.

Regulatory & Marketing

Labeler Name
Bryant Ranch Prepack
Product Type
Human Prescription Drug
FDA Application #
ANDA075614
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
04-30-2021
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (71335-9607). Click a package code to view its specific billing and regulatory data.

71335-9607-1
30 CAPSULE in 1 BOTTLE
71335-9607-3
90 CAPSULE in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 71335-9607-2 identifies a specific commercial package of 28 capsule in 1 bottle of Terazosin, a human prescription drug labeled by Bryant Ranch Prepack. This capsule is formulated for oral use and contains terazosin hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bryant Ranch Prepack on April 30, 2021. The current certification is valid through December 31, 2026.

How is this Bryant Ranch Prepack product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 71335960702. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
71335-9607-2
11-Digit CMS (5-4-2)
71335-9607-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.